Hydrocarbon synthesis

Information

  • Patent Grant
  • 7847139
  • Patent Number
    7,847,139
  • Date Filed
    Wednesday, July 2, 2008
    16 years ago
  • Date Issued
    Tuesday, December 7, 2010
    13 years ago
Abstract
A method of synthesizing hydrocarbons from smaller hydrocarbons includes the steps of hydrocarbon halogenation, simultaneous oligomerization and hydrogen halide neutralization, and product recovery, with a metal-oxygen cataloreactant used to facilitate carbon-carbon coupling. Treatment with air or oxygen liberates halogen and regenerates the cataloreactant.
Description
FIELD OF THE INVENTION

This invention relates generally to hydrocarbon oligomerization, and more particularly to a method of making hydrocarbons using cataloreactants.


BACKGROUND OF THE INVENTION

Scientists have long sought efficient ways to convert methane and other alkanes into higher hydrocarbons, including light olefins and gasoline-range materials. Efficient processes could create value in a number of ways, including: facilitating the utilization of remotely located stranded natural gas through its conversion into more easily transportable liquid fuels and feedstocks, and allowing the use of inexpensive feedstocks (methane and other lower alkanes) for end products often made from higher alkanes, including ethylene and propylene.


U.S. Pat. Nos. 6,486,368, 6,472,572, 6,465,699, 6,465,696, and 6,462,243 disclose processes for converting alkanes into olefins, ethers, and alcohols. Many of the disclosed processes involve halogenation of an alkane, passing the halogenated products over a metal oxide to create products and metal halide, recovering the product(s), and regenerating the metal halide with oxygen or air to yield metal oxide and halogen for recycle to the process. Not described is alkane oligomerization: substantial coupling of the starting hydrocarbon to obtain product(s) of higher carbon number.


Several investigators have examined the use of halogenation for the production of higher hydrocarbons from methane. Representative patents include U.S. Pat. No. 4,513,092 (Chu), U.S. Pat. No. 4,769,504 (Noceti and Taylor), U.S. Pat. No. 5,087,786 (Nubel), and U.S. Pat. No. 6,452,058 (Schweitzer). As described in the Taylor patent: “Aromatic-rich, gasoline boiling range hydrocarbons [are made] from the lower alkanes, particularly from methane. The process is carried out in two stages. In the first, alkane is reacted with oxygen and hydrogen chloride over an oxyhydrochlorination catalyst such as copper chloride with minor proportions of potassium chloride and rare earth chloride. This produces an intermediate gaseous mixture containing water and chlorinated alkanes. The chlorinated alkanes are contacted with a crystalline aluminosilicate catalyst in the hydrogen or metal-promoted form to produce gasoline range hydrocarbons with a high proportion of aromatics and a small percentage of light hydrocarbons (C2-C4), as well as reforming the HCl. The light hydrocarbons can be recycled for further processing over the oxyhydrochlorination catalyst.” All of these techniques for making higher alkanes from C1 feedstocks suffer from the disadvantage that the hydrocarbon stream must be separated from an aqueous hydrohalic acid stream, and the hydrohalic acid stream must be recycled.


U.S. Pat. No. 4,795,843 (Tomotsu et al.) discloses a process for oligomerizing halomethanes to products including ethyl benzene, toluene, and xylenes, using silica polymorph or silicalite catalysts. The process does not incorporate reactive neutralization of hydrogen halide, and appears to suffer from slow kinetics.


In a process for halogenating hydrocarbons, Chang and Perkins noted trace amounts of oligomerization products in the presence of zeolites in U.S. Pat. No. 4,654,449. The oligomerization products were low in quantity, and generally halogenated.


U.S. Pat. No. 4,373,109 (Olah) discloses a process for converting heterosubstituted methanes, including methyl halides, by contacting such methanes with bifunctional acid-base catalysts at elevated temperatures, between 200 and 450 C, preferably between 250 and 375 C, to produce predominantly lower olefins, preferably ethylene and propylene. The catalysts of preference are those derived from halides, oxyhalides, oxides, sulfides or oxysulfides of transition metals of Groups IV, V, VI, VIII of the Periodic Table, such as tantalum, niobium, zirconium, tungsten, titanium, and chromium, deposited on acidic oxides and sulfides such as alumina, silica, zirconia or silica-alumina. Neither the use of solid oxide-based halogen recovery nor the formation of alcohols or ethers is disclosed. A related reference is “Ylide chemistry. 1. Bifunctional acid-base-catalyzed conversion of heterosubstituted methanes into ethylene and derived hydrocarbons. The onium-ylide mechanism of the C1→C2 conversion” by George A. Olah et al. (J. Am. Chem. Soc. 106, 2143 (1984)).


U.S. Pat. No. 3,894,107 (Butter, et al.) discloses improvements to a process for condensing halogenated hydrocarbons using zeolite catalysts. Notably absent is any discussion of solid oxide-based hydrogen halide neutralization.


Kochi has observed reductive coupling of alkyl halides when transition metal bromides are reacted with low-molecular weight Grignard reagents in THF or diethyl ether (Bulletin of the Chemical Society of Japan v. 44 1971 pp. 3063-73). Liquid phase chemistry, however, typically suffers from such disadvantages as the requirement of solvent, corrosion, and lower rates of reaction than gas-phase chemistry. In addition, such a process consumes energy required to produce the magnesium metal needed for the energetic and reducing Grignard reagents. This is not the same type of process as the dehydrohalogenative coupling and hydrogen halide neutralization we describe herein.


SUMMARY OF THE INVENTION

The present invention addresses the need for an efficient way to convert methane and other hydrocarbons into higher hydrocarbons. In one embodiment, a hydrocarbon having a carbon number Cn, where n≧2, is prepared by allowing a reactant hydrocarbon having a carbon number Cm, where m<n, to react with a halogenating agent, thereby forming a halogenated hydrocarbon; allowing the halogenated hydrocarbon to contact a metal-oxygen cataloreactant, thereby forming a product hydrocarbon having an carbon number Cn, where n≧2; recovering the product hydrocarbon; and regenerating the cataloreactant. Often, a mixture of hydrocarbons is obtained, but careful selection of the reactant hydrocarbon, halogenating agent, metal-oxygen cataloreactant, and reaction conditions allow a tailored approach to hydrocarbon product formation. Methane (i.e., natural gas) as well as other light hydrocarbons, e.g., C2 to C6 hydrocarbons, are envisioned as preferred feedstocks.


Although laboratory observations have thus far focused on methane oligomerization with detection of ethylene, propylene, butenes and aromatics, the invention contemplates the use of feedstocks having carbon numbers as high as C10.







DETAILED DESCRIPTION OF THE INVENTION

The present invention exploits the discovery that metal-oxygen compounds, such as mixed metal oxides, particularly metal oxide-impregnated zeolites, facilitate hydrocarbon oligomerization. According to one aspect of the invention, a hydrocarbon having a carbon number Cn, where n≧2, is formed by (i) forming a halogenated hydrocarbon by allowing a reactant hydrocarbon having a carbon number Cm, where m<n, to react with a halogenating agent; (ii) forming a product hydrocarbon having a carbon number Cn, where n≧2, by allowing the halogenated hydrocarbon to contact a metal-oxygen cataloreactant; (iii) recovering the product hydrocarbon; and (iv) regenerating the cataloreactant.


More generally, the method entails the steps of halogenation, oligomerization, product recovery, and cataloreactant regeneration. The halogenated products may be separated from the unreacted (non-halogenated) hydrocarbon either before or after reaction with the metal-oxygen cataloreactant. Neutralization of any hydrohalic acid formed during the synthesis is advantageously accomplished concommitantly with carbon-carbon coupling and/or cataloreactant regeneration. Preferably, the process is an integrated one and takes place, for example, in a zone reactor, as described, for example, in U.S. Pat. No. 6,525,230 (Grosso), the entire contents of which is incorporated by reference herein. Thus, halogenation of methane or other hydrocarbons occurs within one zone of the reactor, and is followed by a condensation step in which the liberated hydrohalic acid is adsorbed within the same bifunctional material that catalyzes condensation of the halogenated hydrocarbon. Hydrocarbon oligomerization (defined as carbon-carbon coupling) takes place within this zone of the reactor and yields product hydrocarbons which, in general, will have carbon numbers ranging from C2 to C20, and may include alkanes, alkenes, alkynes, and/or aromatics. Treatment with air or oxygen liberates halogen for use in subsequent halogenation steps, and regenerates the cataloreactant material for subsequent condensation or metathesis. Advantageously, the need for recycling/recovering corrosive, aqueous hydrohalic acid is avoided because regeneration and recovery takes place in situ.


Higher hydrocarbon synthesis begins with a hydrocarbon feedstock: one or more reactant hydrocarbons, each having, independently, a carbon number Cm, where m<n, Cn being the carbon number of the target hydrocarbon(s). Non-limiting examples of reactant hydrocarbons include methane, ethane, propane, etc., with natural gas (predominately methane, but often including small amounts of C2 and higher species) being preferred. In general, the starting hydrocarbon has a carbon number between 1 and 10. Mixtures of hydrocarbons may also be used.


The reactant hydrocarbons are allowed to react with a halogenating agent. Non-limiting examples include molecular halogen (e.g., bromine, chlorine, etc.), alkyl halides (e.g., dibromomethane, bromoform, carbon tetrabromide), and condensed halides, such as metal bromides, which may be present as a solid, liquid, supported, or unsupported material.


Molecular halogens are preferred, with bromine (Br2) being most preferred. Bromine is a liquid at room temperature, less reactive than chlorine and fluorine, and easy to handle. Bromine also has favorable energetics.


The reduction potential of bromine to bromide is 1.07 V vs. NHE, while that of oxygen to water is 1.23 V. A broad range of metal bromides may release bromine upon treatment with oxygen. At the same time, alkane bromination and subsequent alkyl bromide coupling and HBr neutralization are only mildly exothermic, but spontaneous enough to go to completion. Water and coupled hydrocarbons are the only fluid products. The same is not true with chlorine as mediator, for which HCl is a major component of the product stream. Hydrogen chloride production requires separation, drying, and recycling, which is costly. In short, the thermochemistry of metal bromide-mediated alkane partial oxidiation is well-suited for efficient and inexpensive plant operation.


Halogenation of the reactant hydrocarbon may proceed in a number of ways, depending in part on the desired product(s) and in part on the feed. In one embodiment, an alkane is halogenated with molecular halogen using heat, light, or other electromagnetic radiation to drive the reaction, with heat being preferred. There is some benefit in having all steps—halogenation, oligomerization, and regeneration (described below)—occur at roughly the same temperature. As typical temperatures for methanol to olefin (MTO) and methanol to gasoline (MTG) processes, temperatures of from 375 to 450° C. are utilized, with the range being important, if not critical. For the carbon-carbon coupling process described herein, an ideal temperature range, where all steps occur at roughly the same temperature, is 450 to 550° C. Alternatively, individual reaction steps might be carried out at temperatures above or below this range.


Halogenation preferably occurs at a pressure between 0.1 and 200 atm, for the subsequent carbon-carbon step. Low pressure favors less carbon-carbon coupling (i.e., a smaller average molecular weight of product), while high pressure favors higher coupling. Processes for light olefins are likely to run at the same 60 to 200 psia that methanol to olefin (MTO) processes are run at, although higher pressures may alternatively be utilized. For production of gasoline-range molecules, pressures around 350 psia, as used in methanol to gasoline (MTG) processes, are envisioned. As a practical matter, running below atmospheric (more conservatively, below 2 psia) or above 100 atm is unlikely.


When molecular halogen is used as the halogenating agent, halogenation ideally is carried out at an alkane:halogen ratio of between 1:10 and about 100:1, on a volume by volume basis. At alkane:halogen ratios of less than 1:10 (i.e., more halogen), multi-halogenated hydrocarbons will be formed, typically leading to complete oxidation (i.e., CO2) upon subsequent contact with the metal-oxygen cataloreactant. At alkane:halogen ratios higher than 100:1, the conversion to a halogenated hydrocarbon will be too low, perhaps 1% or less, and it is nearly impossible to imagine an economical process at such conversion levels. (30-60% conversion are more likely lower limits).


Altering the ratio of halogen to alkane or other hydrocarbon feedstock may have a marked impact on product distribution. For example, one may choose to control the degree of halogenation in order to reduce aromatic formation in the production of lower olefins or fuels. A second example is minimizing formation of highly halogenated methane in order to reduce the formation of alkynes.


A key feature of the invention is the use of a metal-oxygen cataloreactant, which facilitates carbon-carbon coupling, i.e., hydrocarbon oligomerization. The term “metal-oxygen cataloreactant” is used herein to refer to a cataloreactant material containing both metal and oxygen. While not bound by theory, it is believed that the material catalyzes carbon-carbon coupling via hydrogen halide (e.g., HBr) elimination and alkyldiene insertion into cationically activated C—H and possibly C—C bonds. The cataloreactant also acts as a halogen release and sequestering agent, and offers the possibility of obtaining a tunable coupling product distribution, including the ability to produce oxygenates if desired, while simultaneously trapping and recovering halogen, emitting only water as a byproduct. Treatment with air or oxygen regenerates the cataloreactant.


Nonlimiting examples of metal-oxygen cataloreactants include zeolites, doped zeolites, metal oxides, mixed metal oxides, metal oxide-impregnated zeolites, and similar materials, as well as mixtures of such materials. Nonlimiting examples of dopants include calcium and magnesium, and their oxides and/or hydroxides.


Zeolites are available from a variety of sources, including Zeolyst International (Valley Forge, Pa.). Specific examples include doped-ZSM-5 and doped mordenite (where, e.g., calcium and/or magnesium are the dopants).


Shifting the properties of the zeolite or zeolite component of a zeolite/metal oxide composite is also expected to shift product distribution. Pore size and acidity are particularly expected to be important. Acidity may be used to control chain length and functionality, and pore size may control chain length and functionality. Zeolites of particular pore-size may selectively produce benzene, toluene, para-xylene, ortho-xylene, meta-xylene, mixed xylenes, ethyl benzene, styrene, linear alkyl benzene, or other aromatic products. The use of pore size is not limited to aromatic products.


In one embodiment of the invention, a metal oxide/zeolite composite is prepared by mixing a zeolite with a metal nitrate (e.g., calcium nitrate) or hydrated species thereof.


After oligomerization, the metal-oxygen cataloreactant is regenerated by treatment with air or oxygen, typically at a temperature of from 200 to 900° C. This converts metal halide species into metal-oxygen species.


A number of variables, including feed composition, feed location in the reactor, temperature, pressure, metal oxide composition, and reactor residence time may alter the product distribution. Production of alkanes, olefins and aromatics from methane has been detected and confirmed. Also expected is the ability to produce alkanes and olefins of particular branching (including mono-methyl branched alcohols), alcohols, diols, ethers, halogenated hydrocarbons, aromatics including benzene, styrene, ethyl benzene, toluene, xylenes, and linear alkyl benzenes, and hydrocarbons suitable for fuels such as gasoline, diesel, and jet fuel.


Control of the feed composition can control the product distribution. First, hydrogen halide produced in the halogenation may be neutralized (to form water or alcohol) with the same metal-oxygen compound producing the hydrocarbon product(s), or with a separate metal-oxygen compound in a distinct reactor. Shifting the hydrogen halide neutralization location may shift the product distribution, including functionality, chain length, and branching. For example, concurrent neutralization and product formation may be expected to drive the production of alcohols, which may or may not undergo further reactions such as coupling or dehydration. Second, water addition to the feed may shift product distribution. In particular, the addition of water may favor alcohol products. The addition of water may also control degree and type of branching and chain length. Third, hydrogen addition may alter the product distribution. Hydrogen may increase alkanes at the expense of other functionalities, something particularly useful for producing fuels. Hydrogen may also reduce coking and help control the chain length and branching.


It will also be appreciated that carbon-carbon oligomerization may proceed by a number of pathways. Even single-hydrocarbon feedstocks may yield more than one product. On the other hand, in one embodiment of the invention, controlled halogentation is used to produce predominately one isomer in favor of another (e.g., selective formation of 1-butene or 2-butene). Mixed feedstocks, such as raw natural gas, may give rise to oligomerization of multiple halogenated hydrocarbons (e.g., ethyl halide, dihaloethane, methyl halide, methyl dihalide, propyl halide, propyl dihalide, etc.). Indeed, in one embodiment of the invention, an alkyl halide is purposefully introduced to create desired branched products. An example would be oligomerization of methyl halide (from methane) with ethyl halide or a higher alkyl halide to produce, selectively, methyl, ethyl, propyl, isopropyl, or tertiary butyl (or other) branching. Another example might be the synthesis of styrene from ethyl halide, methyl halide, and dihalomethane.


In one embodiment of the invention, the reaction of halogenated hydrocarbon with a metal-oxygen cataloreactant takes place in a fluidized bed. Alternatively, a fixed bed is employed. Different alkyl halides may be introduced at different locations in the reactor. One example is the introduction of methyl halides at one location in a reactor to produce benzene, to which ethyl halides are added, producing styrene or ethyl benzene. Another example is the introduction of methyl halides at one location in a reactor to produce benzene, to which alkyl halides are added, producing linear alkyl benzene.


Product separation is accomplished by any suitable method. Nonlimiting examples include distillation, adsorption, and extraction. Product(s) may be recovered from the solid by stripping with steam, carbon dioxide, or other means.


The following are nonlimiting examples of the invention:


EXAMPLE 1

Metal Oxide/Zeolite composite MZ1 was prepared as follows: A solid mixture of a ZSM-5-type zeolite (Zeolyst CBV 8014, Si/Al ratio=80, 10 g, 170 mmoles SiO2) and CaNO3 nonahydrate (9 g, =34 mmoles Ca) was prepared and water was added to incipient wetness. After CaNO3 dissolution and stirring, the slurry was dried and calcined in sequence at 115 C (overnight) and 500 C (overnight), respectively, in air.


EXAMPLE 2

Methane at 15 psia was bubbled through bromine at 1° C. at a rate of 5 cc/min. The resulting stream of bromine and methane (1:10 by mole) was passed through a small diameter bromination reactor at 450° C. (1000 h−1) and the mixture of CH4-xBrx (x=0, 1, 2, 3) passed into a reactor containing 5 g of metal oxide/zeolite composite MZ1 (400 C). The output stream from the second reactor contained no brominated products. Based on the methane consumed in the bromination reactor, 10% ethylene, 31% propylene, 3% propane, and 1% butanes/butenes were detected; 65% overall. Trace amounts of C6 species were also detected. After reaction for 5 hours, during which the stream output did not change from the distribution described above, the methane stream was discontinued and the reactor was purged with helium at 5 cc/min for 10 minutes. After He purge, a flow of O2 (2 cc/min) into the second reactor was initiated at 525 C to regenerate the metal oxide from the metal bromide of the partially spent composite. Initially only water and CO2 were observed as products, but abruptly the stream contents changed to Br2 and unreacted O2. After 1 hour, the O2 purge was discontinued and the reactor was again purged with helium. The caustic trap used during regeneration was tested for CO3−2 and 1.0 mmol was found, representing 24% of the converted carbon. The remainder of carbon was found to be higher boiling volatile aromatics (mostly toluene, xylenes and mesitylenes). A second cycle of bromomethanes condensation as described above was initiated at 400° C. and the product distribution was found to be identical to the first run. Three more cycles of condensation/neutralization/regeneration produced the same output of higher hydrocarbons.


EXAMPLE 3

A doped mordenite (Zeolyst CBV 21A, doped with both Ca and Mg) (5 g) was prepared according to Example 1, and used as the cataloreactant in a hydrocarbon synthesis substantially similar to that described above in Example 2. The product output was 30% ethylene, 5% ethane, 10% propylene, 3% propane, 5% butanes/butenes. Multiple runs and cataloreactant regeneration established reproducibility.


The invention has been described by reference to various examples and preferred embodiments, but is not limited thereto. Other modifications and substitutions can be made without departing from the scope of the invention. For example, the oligomerization processes described herein are also intended to encompass halogenation of olefin feedstocks using a hydrogen halide (e.g., HBr) or molecular halogen; halogenation of acetylenes (alkynes) using hydrogen halide or molecular halogen; halogenation of alcohols or ethers using hydrogen halide or molecular halogen; and halogenation of alkanes using molecular halogen and a catalyst that controls the halogenation. Specifically, the catalyst may control one or both of the degree of halogenation (number of halogens per molecule) and the position of halogenation (e.g. terminal vs. internal halogenation for a long chain alkane). Other modifications may be made as well. The invention is limited only by the appended claims and equivalents thereof.

Claims
  • 1. A method of making a hydrocarbon having a carbon number Cn, where n≧2, comprising: forming a halogenated hydrocarbon by allowing a reactant hydrocarbon having a carbon number Cm, where m<n, to react with a halogenating agent;forming a hydrogen halide and a product hydrocarbon having a carbon number Cn, where n≧2, by allowing the halogenated hydrocarbon to contact a metal-oxygen cataloreactant;trapping halogen from the hydrogen halide with the metal-oxygen cataloreactant;recovering the product hydrocarbon; andregenerating the metal-oxygen cataloreactant to recover the halogen.
  • 2. A method as recited in claim 1, wherein the reactant hydrocarbon comprises methane.
  • 3. A method as recited in claim 1, wherein the metal-oxygen cataloreactant is selected from the group consisting of zeolites, doped zeolites, metal oxides, mixed metal oxides, metal oxide-impregnated zeolites, and mixtures thereof.
  • 4. A method as recited in claim 1, wherein the metal-oxygen cataloreactant is regenerated with air or oxygen.
  • 5. A method as recited in claim 1, wherein formation of the product hydrocarbon is carried out in a zone reactor.
  • 6. A method as recited in claim 1, wherein the halogenating agent comprises molecular halogen.
  • 7. A method as recited in claim 1, wherein the halogenating agent comprises bromine.
  • 8. A method as recited in claim 1, wherein the halogenating agent comprises an alkyl halide.
  • 9. A method as recited in claim 1, wherein the halogenating agent comprises a solid halide.
  • 10. A method as recited in claim 1, wherein the halogenating agent comprises a hydrogen halide.
  • 11. A method of making a hydrocarbon having a carbon number Cn, where n≧2, comprising: forming hydrogen bromide and a brominated hydrocarbon by allowing a reactant hydrocarbon having a carbon number Cm, where m<n, to react with a brominating agent;forming a product hydrocarbon having a carbon number Cn, where n≧2, by allowing the brominated hydrocarbon to contact a metal-oxygen cataloreactant;trapping bromine from the hydrogen bromide with the metal-oxygen cataloreactant;recovering the product hydrocarbon; andregenerating the metal-oxygen cataloreactant to recover the bromine.
  • 12. A method as recited in claim 11, wherein the reactant hydrocarbon comprises methane.
  • 13. A method as recited in claim 11, wherein the metal-oxygen cataloreactant is selected from the group consisting of zeolites, doped zeolites, metal oxides, mixed metal oxides, metal oxide-impregnated zeolites, and mixtures thereof.
  • 14. A method as recited in claim 11, wherein the metal-oxygen cataloreactant is regenerated with air or oxygen.
  • 15. A method as recited in claim 11, wherein formation of the product hydrocarbon is carried out in a zone reactor.
  • 16. A method as recited in claim 11, wherein the brominating agent is selected from the group consisting of bromine, alkyl bromides, solid bromides, and hydrogen bromide.
  • 17. A method of making a hydrocarbon having a carbon number Cn, where n≧2, comprising: (i) forming a hydrogen halide and an alkyl halide by allowing a reactant alkane having a carbon number Cm, where m<n, to react with molecular halogen;(ii) forming a product hydrocarbon having a carbon number Cn, where n≧2, by allowing the alkyl halide to contact a metal-oxygen cataloreactant;(iii) trapping halogen from the hydrogen halide with the metal-oxygen cataloreactant;(iv) recovering the product hydrocarbon; and(v) regenerating the metal-oxygen cataloreactant with air or oxygen to recover the halogen.
  • 18. A method as recited in claim 17, wherein the reactant alkane comprises methane.
  • 19. A method as recited in claim 17, wherein the molecular halogen comprises bromine.
  • 20. A method as recited in claim 17, wherein step (i) occurs at an alkane-to-halogen ratio of from 1:10 to 100:1 by volume.
  • 21. A method as recited in claim 19, wherein step (i) occurs at a temperature of from 20 to 900° C. and a pressure of from 0.1 to 200 atm.
  • 22. A method as recited in claim 17, wherein the metal-oxygen cataloreactant is selected from the group consisting of zeolites, doped zeolites, metal oxides, mixed metal oxides, metal oxide-impregnated zeolites, and mixtures thereof.
  • 23. A method as recited in claim 17, wherein steps (i)-(v) take place in a zone reactor.
  • 24. A method of making a hydrocarbon having a carbon number Cn, where n≧2, comprising: (i) forming hydrogen bromide and an alkyl bromide by allowing methane to react with molecular bromine, at a temperature of from 20 to 900° C., a pressure of from 0.1 to 200 atm, and a methane-to-bromine ratio of from 1:10 to 100:1 by volume;(ii) forming a product hydrocarbon having a carbon number Cn, where n≧2, by allowing the alkyl bromide to contact a doped zeolite;(iii) trapping bromine from the hydrogen bromide with the doped zeolite;(iv) recovering the product hydrocarbon; and(v) regenerating the doped zeolite with air or oxygen to recover the bromine; wherein steps (i)-(v) occur in a zone reactor.
  • 25. A method of making a product hydrocarbon comprising: reacting a halogenating agent with a reactant hydrocarbon having a carbon number Cm, where m<n, to form a halogenated hydrocarbon;contacting the halogenated hydrocarbon with a metal-oxygen cataloreactant to catalyze formation of a product hydrocarbon having a carbon number Cn, where n≧2, while halogenating the cataloreactant to form a halogenated cataloreactant;recovering the product hydrocarbon;reacting the halogenated cataloreactant with oxygen or air to regenerate the cataloreactant and form a molecular halogen; andrecycling the molecular halogen as the halogenating agent to react with the reactant hydrocarbon.
CROSS-REFERENCE TO RELATED APPLICATION(S)

This application is a continuation of U.S. patent application Ser. No. 10/893,418, filed Jul. 15, 2004, now abandoned which claims the benefit of U.S. Provisional Patent Application No. 60/487,364, filed Jul. 15, 2003. The disclosures of both applications are incorporated by reference herein as if set forth in their entirety.

US Referenced Citations (539)
Number Name Date Kind
2168260 Heisel et al. Aug 1939 A
2246082 Vaughan et al. Jun 1941 A
2488083 Gorin et al. Nov 1949 A
2677598 Crummett et al. May 1954 A
2941014 Rothweiler et al. Jun 1960 A
3076784 Huermann et al. Feb 1963 A
3172915 Borkowski et al. Mar 1965 A
3246043 Rosset et al. Apr 1966 A
3294846 Livak et al. Dec 1966 A
3310380 Lester Mar 1967 A
3346340 Louvar et al. Oct 1967 A
3353916 Lester Nov 1967 A
3353919 Stockman Nov 1967 A
3496242 Berkowitz et al. Feb 1970 A
3562321 Borkowski et al. Feb 1971 A
3598876 Bloch Aug 1971 A
3657367 Blake et al. Apr 1972 A
3670037 Dugan Jun 1972 A
3673264 Kuhn Jun 1972 A
3679758 Schneider Jul 1972 A
3702886 Argauer et al. Nov 1972 A
3705196 Turner Dec 1972 A
3799997 Schmerling Mar 1974 A
3865886 Schindler et al. Feb 1975 A
3876715 McNulty et al. Apr 1975 A
3879473 Stapp Apr 1975 A
3879480 Riegel et al. Apr 1975 A
3883651 Woitun et al. May 1975 A
3886287 Kobayashi et al. May 1975 A
3894103 Chang et al. Jul 1975 A
3894104 Chang et al. Jul 1975 A
3894105 Chang et al. Jul 1975 A
3894107 Butter et al. Jul 1975 A
3907917 Forth Sep 1975 A
3919336 Kurtz Nov 1975 A
3920764 Riegel et al. Nov 1975 A
3923913 Antonini et al. Dec 1975 A
3928483 Chang et al. Dec 1975 A
3965205 Garwood et al. Jun 1976 A
3974062 Owen et al. Aug 1976 A
3987119 Kurtz et al. Oct 1976 A
3992466 Plank et al. Nov 1976 A
4006169 Anderson et al. Feb 1977 A
4011278 Plank et al. Mar 1977 A
4025571 Lago May 1977 A
4025572 Lago May 1977 A
4025575 Chang et al. May 1977 A
4025576 Chang et al. May 1977 A
4035285 Owen et al. Jul 1977 A
4035430 Dwyer et al. Jul 1977 A
4039600 Chang Aug 1977 A
4044061 Chang et al. Aug 1977 A
4046825 Owen et al. Sep 1977 A
4049734 Garwood et al. Sep 1977 A
4052471 Pearsall Oct 1977 A
4052472 Given et al. Oct 1977 A
4058576 Chang et al. Nov 1977 A
4060568 Rodewald Nov 1977 A
4071753 Fulenwider et al. Jan 1978 A
4072733 Hargis et al. Feb 1978 A
4087475 Jordan May 1978 A
4088706 Kaeding May 1978 A
4092368 Smith May 1978 A
4110180 Nidola et al. Aug 1978 A
4117251 Kaufhold et al. Sep 1978 A
4129604 Tsao Dec 1978 A
4133838 Pearson Jan 1979 A
4133966 Pretzer et al. Jan 1979 A
4138440 Chang et al. Feb 1979 A
4156698 Dwyer et al. May 1979 A
4169862 Eden Oct 1979 A
4172099 Severino Oct 1979 A
4187255 Dodd Feb 1980 A
4194990 Pieters et al. Mar 1980 A
4197420 Ferraris et al. Apr 1980 A
4219680 Konig et al. Aug 1980 A
4249031 Drent et al. Feb 1981 A
4270929 Dang Vu et al. Jun 1981 A
4272338 Lynch et al. Jun 1981 A
4282159 Davidson et al. Aug 1981 A
4300005 Li Nov 1981 A
4300009 Haag et al. Nov 1981 A
4301253 Warren Nov 1981 A
4302619 Gross et al. Nov 1981 A
4307261 Beard, Jr. et al. Dec 1981 A
4308403 Knifton Dec 1981 A
4311865 Chen et al. Jan 1982 A
4317800 Sloterdijk et al. Mar 1982 A
4317934 Seemuth Mar 1982 A
4317943 Knifton Mar 1982 A
4320241 Frankiewicz Mar 1982 A
4333852 Warren Jun 1982 A
4347391 Campbell Aug 1982 A
4350511 Holmes et al. Sep 1982 A
4371716 Paxson et al. Feb 1983 A
4373109 Olah Feb 1983 A
4376019 Gamlen et al. Mar 1983 A
4380682 Leitert et al. Apr 1983 A
4384159 Diesen May 1983 A
4389391 Dunn Jun 1983 A
4410714 Apanel Oct 1983 A
4412086 Beard, Jr. et al. Oct 1983 A
4418236 Cornelius et al. Nov 1983 A
4431856 Daviduk et al. Feb 1984 A
4433189 Young Feb 1984 A
4433192 Olah Feb 1984 A
4439409 Puppe et al. Mar 1984 A
4440871 Lok et al. Apr 1984 A
4443620 Gelbein et al. Apr 1984 A
4462814 Holmes et al. Jul 1984 A
4465884 Degnan et al. Aug 1984 A
4465893 Olah Aug 1984 A
4467130 Olah Aug 1984 A
4467133 Chang et al. Aug 1984 A
4489210 Judat et al. Dec 1984 A
4489211 Ogura et al. Dec 1984 A
4492657 Heiss Jan 1985 A
4496752 Gelbein et al. Jan 1985 A
4497967 Wan Feb 1985 A
4499314 Seddon et al. Feb 1985 A
4506105 Kaufhold Mar 1985 A
4509955 Hayashi Apr 1985 A
4513092 Chu et al. Apr 1985 A
4513164 Olah Apr 1985 A
4523040 Olah Jun 1985 A
4524227 Fowles et al. Jun 1985 A
4524228 Fowles et al. Jun 1985 A
4524231 Fowles et al. Jun 1985 A
4538014 Miale et al. Aug 1985 A
4538015 Miale et al. Aug 1985 A
4540826 Banasiak et al. Sep 1985 A
4543434 Chang Sep 1985 A
4544781 Chao et al. Oct 1985 A
4547612 Tabak Oct 1985 A
4550217 Graziani et al. Oct 1985 A
4550218 Chu Oct 1985 A
4568660 Klosiewicz Feb 1986 A
4579977 Drake Apr 1986 A
4579992 Kaufhold et al. Apr 1986 A
4579996 Font Freide et al. Apr 1986 A
4587375 Debras et al. May 1986 A
4588835 Torii et al. May 1986 A
4590310 Townsend et al. May 1986 A
4599474 Devries et al. Jul 1986 A
4605796 Isogai et al. Aug 1986 A
4605803 Chang et al. Aug 1986 A
4621161 Shihabi Nov 1986 A
4621164 Chang et al. Nov 1986 A
4633027 Owen et al. Dec 1986 A
4634800 Withers, Jr. et al. Jan 1987 A
4642403 Hyde et al. Feb 1987 A
4642404 Shihabi Feb 1987 A
4652688 Brophy et al. Mar 1987 A
4654449 Chang et al. Mar 1987 A
4655893 Beale Apr 1987 A
4658073 Tabak Apr 1987 A
4658077 Kolts et al. Apr 1987 A
4665259 Brazdil et al. May 1987 A
4665267 Barri May 1987 A
4665270 Brophy et al. May 1987 A
4675410 Feitler et al. Jun 1987 A
4690903 Chen et al. Sep 1987 A
4695663 Hall et al. Sep 1987 A
4696985 Martin Sep 1987 A
4704488 Devries et al. Nov 1987 A
4704493 Devries et al. Nov 1987 A
4709108 Devries et al. Nov 1987 A
4720600 Beech, Jr. et al. Jan 1988 A
4720602 Chu Jan 1988 A
4724275 Hinnenkamp et al. Feb 1988 A
4735747 Ollivier et al. Apr 1988 A
4737594 Olah Apr 1988 A
4748013 Saito et al. May 1988 A
4769504 Noceti et al. Sep 1988 A
4774216 Kolts et al. Sep 1988 A
4775462 Imai et al. Oct 1988 A
4777321 Harandi et al. Oct 1988 A
4781733 Babcock et al. Nov 1988 A
4783566 Kocal et al. Nov 1988 A
4788369 Marsh et al. Nov 1988 A
4788377 Chang et al. Nov 1988 A
4792642 Rule et al. Dec 1988 A
4795732 Barri Jan 1989 A
4795737 Rule et al. Jan 1989 A
4795843 Imai et al. Jan 1989 A
4795848 Teller et al. Jan 1989 A
4804797 Minet et al. Feb 1989 A
4804800 Bortinger et al. Feb 1989 A
4808763 Shum Feb 1989 A
4814527 Diesen Mar 1989 A
4814532 Yoshida et al. Mar 1989 A
4814535 Yurchak Mar 1989 A
4814536 Yuchak Mar 1989 A
4849562 Buhs et al. Jul 1989 A
4849573 Kaefing Jul 1989 A
4851602 Harandi et al. Jul 1989 A
4851606 Ragonese et al. Jul 1989 A
4886925 Harandi Dec 1989 A
4886932 Leyshon Dec 1989 A
4891463 Chu Jan 1990 A
4895995 James, Jr. et al. Jan 1990 A
4899000 Stauffer Feb 1990 A
4899001 Kalnes et al. Feb 1990 A
4899002 Harandi et al. Feb 1990 A
4902842 Kalnes et al. Feb 1990 A
4925995 Robschlager May 1990 A
4929781 James, Jr. et al. May 1990 A
4939310 Wade Jul 1990 A
4939311 Washecheck et al. Jul 1990 A
4945175 Hobbs et al. Jul 1990 A
4950811 Doussain et al. Aug 1990 A
4950822 Dileo et al. Aug 1990 A
4956521 Volles Sep 1990 A
4962252 Wade Oct 1990 A
4973776 Allenger et al. Nov 1990 A
4973786 Karra Nov 1990 A
4982024 Lin et al. Jan 1991 A
4982041 Campbell Jan 1991 A
4988660 Campbell Jan 1991 A
4990696 Stauffer Feb 1991 A
4990711 Chen et al. Feb 1991 A
5001293 Nubel et al. Mar 1991 A
5004847 Beaver et al. Apr 1991 A
5013424 James, Jr. et al. May 1991 A
5013793 Wang et al. May 1991 A
5019652 Taylor et al. May 1991 A
5026934 Bains et al. Jun 1991 A
5026937 Bricker Jun 1991 A
5026944 Allenger et al. Jun 1991 A
5034566 Ishino et al. Jul 1991 A
5043502 Martindale et al. Aug 1991 A
5055235 Brackenridge et al. Oct 1991 A
5055633 Volles Oct 1991 A
5055634 Volles Oct 1991 A
5059744 Harandi et al. Oct 1991 A
5068478 Miller et al. Nov 1991 A
5071449 Sircar Dec 1991 A
5071815 Wallace Dec 1991 A
5073656 Chafin et al. Dec 1991 A
5073657 Warren Dec 1991 A
5082473 Keefer Jan 1992 A
5082816 Teller et al. Jan 1992 A
5085674 Leavitt Feb 1992 A
5087779 Nubel et al. Feb 1992 A
5087786 Nubel et al. Feb 1992 A
5087787 Kimble et al. Feb 1992 A
5093542 Gaffney Mar 1992 A
5096469 Keefer Mar 1992 A
5097083 Stauffer Mar 1992 A
5099084 Stauffer Mar 1992 A
5105045 Kimble et al. Apr 1992 A
5105046 Washecheck Apr 1992 A
5107032 Erb et al. Apr 1992 A
5107051 Pannell Apr 1992 A
5107061 Ou et al. Apr 1992 A
5108579 Casci Apr 1992 A
5118899 Kimble et al. Jun 1992 A
5120332 Wells Jun 1992 A
5132343 Zwecker et al. Jul 1992 A
5138112 Gosling et al. Aug 1992 A
5139991 Taylor et al. Aug 1992 A
5146027 Gaffney Sep 1992 A
5157189 Karra Oct 1992 A
5160502 Kimble et al. Nov 1992 A
5166452 Gradl et al. Nov 1992 A
5175382 Hebgen et al. Dec 1992 A
5178748 Casci et al. Jan 1993 A
5185479 Stauffer Feb 1993 A
5188725 Harandi Feb 1993 A
5191142 Marshall et al. Mar 1993 A
5194244 Brownscombe et al. Mar 1993 A
5202506 Kirchner et al. Apr 1993 A
5202511 Salinas, III et al. Apr 1993 A
5210357 Kolts et al. May 1993 A
5215648 Zones et al. Jun 1993 A
5223471 Washecheck Jun 1993 A
5228888 Gmelin et al. Jul 1993 A
5233113 Periana et al. Aug 1993 A
5237115 Makovec et al. Aug 1993 A
5243098 Miller et al. Sep 1993 A
5243114 Johnson et al. Sep 1993 A
5245109 Kaminsky et al. Sep 1993 A
5254772 Dukat et al. Oct 1993 A
5254790 Thomas et al. Oct 1993 A
5264635 Le et al. Nov 1993 A
5268518 West et al. Dec 1993 A
5276226 Horvath et al. Jan 1994 A
5276240 Timmons et al. Jan 1994 A
5276242 Wu Jan 1994 A
5284990 Peterson et al. Feb 1994 A
5300126 Brown et al. Apr 1994 A
5306855 Periana et al. Apr 1994 A
5316995 Kaminsky et al. May 1994 A
5319132 Ozawa et al. Jun 1994 A
5334777 Miller et al. Aug 1994 A
5345021 Casci et al. Sep 1994 A
5354916 Horvath et al. Oct 1994 A
5354931 Jan et al. Oct 1994 A
5366949 Schubert Nov 1994 A
5371313 Ostrowicki Dec 1994 A
5382704 Krespan et al. Jan 1995 A
5382743 Beech, Jr. et al. Jan 1995 A
5382744 Abbott et al. Jan 1995 A
5385718 Casci et al. Jan 1995 A
5395981 Marker Mar 1995 A
5399258 Fletcher et al. Mar 1995 A
5401890 Parks Mar 1995 A
5401894 Brasier et al. Mar 1995 A
5406017 Withers, Jr. Apr 1995 A
5414173 Garces et al. May 1995 A
5430210 Grasselli et al. Jul 1995 A
5430214 Smith et al. Jul 1995 A
5430219 Sanfilippo et al. Jul 1995 A
5436378 Masini et al. Jul 1995 A
5444168 Brown Aug 1995 A
5446234 Casci et al. Aug 1995 A
5453557 Harley et al. Sep 1995 A
5456822 Marcilly et al. Oct 1995 A
5457255 Kumata et al. Oct 1995 A
5464799 Casci et al. Nov 1995 A
5465699 Voigt Nov 1995 A
5470377 Whitlock Nov 1995 A
5480629 Thompson et al. Jan 1996 A
5486627 Quarderer et al. Jan 1996 A
5489719 Le et al. Feb 1996 A
5489727 Randolph et al. Feb 1996 A
5500297 Thompson et al. Mar 1996 A
5510525 Sen et al. Apr 1996 A
5523503 Funk et al. Jun 1996 A
5525230 Wrigley et al. Jun 1996 A
5538540 Whitlock Jul 1996 A
5563313 Chung et al. Oct 1996 A
5565092 Pannell et al. Oct 1996 A
5565616 Li et al. Oct 1996 A
5571762 Clerici et al. Nov 1996 A
5571885 Chung et al. Nov 1996 A
5599381 Whitlock Feb 1997 A
5600043 Johnston et al. Feb 1997 A
5600045 Van Der Aalst et al. Feb 1997 A
5609654 Le et al. Mar 1997 A
5633419 Spencer et al. May 1997 A
5639930 Penick Jun 1997 A
5653956 Zones Aug 1997 A
5656149 Zones et al. Aug 1997 A
5661097 Spencer et al. Aug 1997 A
5663465 Clegg et al. Sep 1997 A
5663474 Pham et al. Sep 1997 A
5675046 Ohno et al. Oct 1997 A
5675052 Menon et al. Oct 1997 A
5679134 Brugerolle et al. Oct 1997 A
5679879 Mercier et al. Oct 1997 A
5684213 Nemphos et al. Nov 1997 A
5693191 Pividal et al. Dec 1997 A
5695890 Thompson et al. Dec 1997 A
5698747 Godwin et al. Dec 1997 A
5705712 Frey et al. Jan 1998 A
5705728 Viswanathan et al. Jan 1998 A
5705729 Huang Jan 1998 A
5708246 Camaioni et al. Jan 1998 A
5720858 Noceti et al. Feb 1998 A
5728897 Buysch et al. Mar 1998 A
5728905 Clegg et al. Mar 1998 A
5734073 Chambers et al. Mar 1998 A
5741949 Mack Apr 1998 A
5744669 Kalnes et al. Apr 1998 A
5750801 Buysch et al. May 1998 A
5770175 Zones Jun 1998 A
5776871 Cothran et al. Jul 1998 A
5780703 Chang et al. Jul 1998 A
5798314 Spencer et al. Aug 1998 A
5814715 Chen et al. Sep 1998 A
5817904 Vic et al. Oct 1998 A
5821394 Schoebrechts et al. Oct 1998 A
5959170 Withers Sep 1999 A
5968236 Bassine Oct 1999 A
5969195 Stabel et al. Oct 1999 A
5998679 Miller Dec 1999 A
6056804 Keefer et al. May 2000 A
6068679 Zheng May 2000 A
6320085 Arvai et al. Nov 2001 B1
6368490 Gestermann Apr 2002 B1
6403840 Zhou et al. Jun 2002 B1
6406523 Connor et al. Jun 2002 B1
6452058 Schweizer et al. Sep 2002 B1
6462243 Zhou et al. Oct 2002 B1
6465696 Zhou et al. Oct 2002 B1
6465699 Grosso Oct 2002 B1
6472572 Zhou et al. Oct 2002 B1
6486368 Zhou et al. Nov 2002 B1
6511526 Jagger et al. Jan 2003 B2
6514319 Keefer et al. Feb 2003 B2
6525230 Grosso Feb 2003 B2
6641644 Jagger et al. Nov 2003 B2
6672572 Werlen Jan 2004 B2
6692626 Keefer et al. Feb 2004 B2
6713087 Tracy et al. Mar 2004 B2
6713655 Yilmaz et al. Mar 2004 B2
RE38493 Keefer et al. Apr 2004 E
6740146 Simonds May 2004 B2
6866950 Connor et al. Mar 2005 B2
6902602 Keefer et al. Jun 2005 B2
6921597 Keefer et al. Jul 2005 B2
6956140 Ehrenfeld Oct 2005 B2
6958306 Holtcamp Oct 2005 B2
6984763 Schweizer et al. Jan 2006 B2
7001872 Pyecroft et al. Feb 2006 B2
7002050 Santiago Fernandez et al. Feb 2006 B2
7011811 Elomari Mar 2006 B2
7019182 Grosso Mar 2006 B2
7026145 Mizrahi et al. Apr 2006 B2
7026519 Santiago Fernandez et al. Apr 2006 B2
7037358 Babicki et al. May 2006 B2
7045670 Johnson et al. May 2006 B2
7049388 Boriack et al. May 2006 B2
7053252 Boussand et al. May 2006 B2
7057081 Allison et al. Jun 2006 B2
7060865 Ding et al. Jun 2006 B2
7064238 Waycuilis Jun 2006 B2
7064240 Ohno et al. Jun 2006 B2
7067448 Weitkamp et al. Jun 2006 B1
7083714 Elomari Aug 2006 B2
7084308 Stauffer Aug 2006 B1
7091270 Zilberman et al. Aug 2006 B2
7091387 Fong et al. Aug 2006 B2
7091391 Stauffer Aug 2006 B2
7094936 Owens et al. Aug 2006 B1
7098371 Mack et al. Aug 2006 B2
7105710 Boons et al. Sep 2006 B2
7138534 Forlin et al. Nov 2006 B2
7141708 Marsella et al. Nov 2006 B2
7145045 Harmsen et al. Dec 2006 B2
7148356 Smith, III et al. Dec 2006 B2
7148390 Zhou et al. Dec 2006 B2
7151199 Martens et al. Dec 2006 B2
7161050 Sherman et al. Jan 2007 B2
7169730 Ma et al. Jan 2007 B2
7176340 Van Broekhoven et al. Feb 2007 B2
7176342 Bellussi et al. Feb 2007 B2
7182871 Perriello Feb 2007 B2
7193093 Murray et al. Mar 2007 B2
7196239 Van Egmond et al. Mar 2007 B2
7199083 Zevallos Apr 2007 B2
7199255 Murray et al. Apr 2007 B2
7208641 Nagasaki et al. Apr 2007 B2
7214750 McDonald et al. May 2007 B2
7220391 Huang et al. May 2007 B1
7226569 Elomari Jun 2007 B2
7226576 Elomari Jun 2007 B2
7230150 Grosso et al. Jun 2007 B2
7230151 Martens et al. Jun 2007 B2
7232872 Shaffer et al. Jun 2007 B2
7238846 Janssen et al. Jul 2007 B2
7244795 Agapiou et al. Jul 2007 B2
7244867 Waycuilis Jul 2007 B2
7250107 Benazzi et al. Jul 2007 B2
7250542 Smith, Jr. et al. Jul 2007 B2
7252920 Kurokawa et al. Aug 2007 B2
7253327 Janssens et al. Aug 2007 B2
7253328 Stauffer Aug 2007 B2
7265193 Weng et al. Sep 2007 B2
7267758 Benazzi et al. Sep 2007 B2
7268263 Frey et al. Sep 2007 B1
7271303 Sechrist et al. Sep 2007 B1
7273957 Bakshi et al. Sep 2007 B2
7282603 Richards Oct 2007 B2
7285698 Liu et al. Oct 2007 B2
7304193 Frey et al. Dec 2007 B1
7342144 Kaizik et al. Mar 2008 B2
7348295 Zones et al. Mar 2008 B2
7348464 Waycuilis Mar 2008 B2
7357904 Zones et al. Apr 2008 B2
7361794 Grosso Apr 2008 B2
7390395 Elomari Jun 2008 B2
20020102672 Mizrahi Aug 2002 A1
20020198416 Zhou et al. Dec 2002 A1
20030004380 Grumann Jan 2003 A1
20030065239 Zhu Apr 2003 A1
20030069452 Sherman et al. Apr 2003 A1
20030078456 Yilmaz et al. Apr 2003 A1
20030120121 Sherman et al. Jun 2003 A1
20030125589 Grosso Jul 2003 A1
20030166973 Zhou et al. Sep 2003 A1
20040006246 Sherman et al. Jan 2004 A1
20040062705 Leduc Apr 2004 A1
20040152929 Clarke Aug 2004 A1
20040158107 Aoki Aug 2004 A1
20040158108 Snoble Aug 2004 A1
20040187684 Elomari Sep 2004 A1
20050047927 Lee et al. Mar 2005 A1
20050148805 Jones Jul 2005 A1
20050171393 Lorkovic Aug 2005 A1
20050192468 Sherman et al. Sep 2005 A1
20050215837 Hoffpauir Sep 2005 A1
20050234276 Waycuilis Oct 2005 A1
20050245772 Fong Nov 2005 A1
20050245777 Fong Nov 2005 A1
20050267224 Herling Dec 2005 A1
20060025617 Begley Feb 2006 A1
20060100469 Waycuilis May 2006 A1
20060135823 Jun Jun 2006 A1
20060138025 Zones Jun 2006 A1
20060138026 Chen Jun 2006 A1
20060149116 Slaugh Jul 2006 A1
20060229228 Komon et al. Oct 2006 A1
20060229475 Weiss et al. Oct 2006 A1
20060270863 Reiling Nov 2006 A1
20060288690 Elomari Dec 2006 A1
20070004955 Kay Jan 2007 A1
20070078285 Dagle Apr 2007 A1
20070100189 Stauffer May 2007 A1
20070129584 Basset Jun 2007 A1
20070142680 Ayoub Jun 2007 A1
20070148067 Zones Jun 2007 A1
20070148086 Zones Jun 2007 A1
20070149778 Zones Jun 2007 A1
20070149789 Zones Jun 2007 A1
20070149819 Zones Jun 2007 A1
20070149824 Zones Jun 2007 A1
20070149837 Zones Jun 2007 A1
20070197801 Bolk Aug 2007 A1
20070197847 Liu Aug 2007 A1
20070213545 Bolk Sep 2007 A1
20070238905 Arredondo Oct 2007 A1
20070238909 Gadewar et al. Oct 2007 A1
20070251382 Gadewar Nov 2007 A1
20070276168 Garel Nov 2007 A1
20070284284 Zones Dec 2007 A1
20080171898 Waycuilis Jul 2008 A1
20080183022 Waycuilis Jul 2008 A1
20080188697 Lorkovic Aug 2008 A1
20080314758 Grosso Dec 2008 A1
20090069606 Komon Mar 2009 A1
20090127163 Weiss May 2009 A1
20100096588 Gadewar Apr 2010 A1
20100099928 Gadewar Apr 2010 A1
20100099929 Gadewar Apr 2010 A1
20100099930 Stoimenov Apr 2010 A1
20100105972 Lorkovic Apr 2010 A1
20100121119 Sherman May 2010 A1
Foreign Referenced Citations (172)
Number Date Country
0210054 Aug 2004 BR
1099656 Apr 1981 CA
1101441 May 1981 CA
1202610 Apr 1986 CA
2447761 Nov 2002 CA
2471295 Jul 2003 CA
2542857 May 2005 CA
2236126 Aug 2006 CA
2203115 Sep 2006 CA
2510093 Dec 2006 CA
0021497 Jan 1981 EP
0164798 Dec 1985 EP
0418971 Mar 1991 EP
0418974 Mar 1991 EP
0418975 Mar 1991 EP
0510238 Oct 1992 EP
0526908 Feb 1993 EP
0346612 Aug 1993 EP
0560546 Sep 1993 EP
0976705 Jul 1998 EP
1186591 Mar 2002 EP
1253126 Oct 2002 EP
1312411 May 2003 EP
1395536 Mar 2004 EP
1404636 Apr 2004 EP
1235769 May 2004 EP
1435349 Jul 2004 EP
1440939 Jul 2004 EP
1474371 Nov 2004 EP
1235772 Jan 2005 EP
1661620 May 2006 EP
1760057 Mar 2007 EP
1689728 Apr 2007 EP
1808227 Jul 2007 EP
1837320 Sep 2007 EP
5125 Feb 1912 GB
156122 Mar 1922 GB
294100 Jun 1929 GB
363009 Dec 1931 GB
402928 Dec 1933 GB
474922 Nov 1937 GB
536491 May 1941 GB
553950 Jun 1943 GB
586483 Mar 1947 GB
775590 May 1957 GB
793214 Apr 1958 GB
796048 Jun 1958 GB
796085 Jun 1958 GB
883256 Nov 1961 GB
950975 Mar 1964 GB
950976 Mar 1964 GB
991303 May 1965 GB
995960 Jun 1965 GB
1015033 Dec 1965 GB
1104294 Feb 1968 GB
1133752 Nov 1968 GB
1172002 Nov 1969 GB
1212240 Nov 1970 GB
1233299 May 1971 GB
1253618 Nov 1971 GB
1263806 Feb 1972 GB
1446803 Aug 1976 GB
1542112 Mar 1979 GB
2095243 Sep 1982 GB
2095245 Sep 1982 GB
2095249 Sep 1982 GB
2116546 Sep 1982 GB
2120249 Nov 1983 GB
2185754 Jul 1987 GB
2191214 Dec 1987 GB
2004-529189 Sep 2004 JP
8300859 Mar 1983 WO
8504863 Nov 1985 WO
8504867 Nov 1985 WO
9008120 Jul 1990 WO
9008752 Aug 1990 WO
9118856 Dec 1991 WO
9203401 Mar 1992 WO
9212946 Aug 1992 WO
9316798 Sep 1993 WO
9622263 Jul 1996 WO
9744302 Nov 1997 WO
9812165 Mar 1998 WO
9907443 Feb 1999 WO
0007718 Feb 2000 WO
0009261 Feb 2000 WO
0114300 Mar 2001 WO
0138275 May 2001 WO
0144149 Jun 2001 WO
02094749 Nov 2002 WO
02094750 Nov 2002 WO
02094751 Nov 2002 WO
02094752 Nov 2002 WO
03000635 Jan 2003 WO
03002251 Jan 2003 WO
03018524 Mar 2003 WO
03020676 Mar 2003 WO
03022827 Mar 2003 WO
03043575 May 2003 WO
03051813 Jun 2003 WO
03062143 Jul 2003 WO
03062172 Jul 2003 WO
03078366 Sep 2003 WO
2004018093 Mar 2004 WO
2004067487 Aug 2004 WO
2005014168 Feb 2005 WO
2005019143 Mar 2005 WO
2005021468 Mar 2005 WO
2005021468 Mar 2005 WO
2005035121 Apr 2005 WO
2005037758 Apr 2005 WO
2005054120 Jun 2005 WO
2005056525 Jun 2005 WO
2005058782 Jun 2005 WO
2005090272 Sep 2005 WO
2005095310 Oct 2005 WO
2005105709 Nov 2005 WO
2005105715 Nov 2005 WO
2005110953 Nov 2005 WO
2005113437 Dec 2005 WO
2005113440 Dec 2005 WO
2006007093 Jan 2006 WO
2006015824 Feb 2006 WO
2006019399 Feb 2006 WO
2006020234 Feb 2006 WO
2006036293 Apr 2006 WO
2006039213 Apr 2006 WO
2006039354 Apr 2006 WO
2006043075 Apr 2006 WO
2006053345 May 2006 WO
2006-067155 Jun 2006 WO
2006067188 Jun 2006 WO
2006067190 Jun 2006 WO
2006067191 Jun 2006 WO
2006067192 Jun 2006 WO
2006067193 Jun 2006 WO
2006069107 Jun 2006 WO
2006071354 Jul 2006 WO
2006076942 Jul 2006 WO
2006083427 Aug 2006 WO
2006-100312 Sep 2006 WO
2006104909 Oct 2006 WO
2006104914 Oct 2006 WO
2006104914 Oct 2006 WO
2006111997 Oct 2006 WO
2006113205 Oct 2006 WO
2006118935 Nov 2006 WO
2007001934 Jan 2007 WO
2007017900 Feb 2007 WO
2007044139 Apr 2007 WO
2007046986 Apr 2007 WO
2007050745 May 2007 WO
2007071046 Jun 2007 WO
2007079038 Jul 2007 WO
2007091009 Aug 2007 WO
2007094995 Aug 2007 WO
2007107031 Sep 2007 WO
2007111997 Oct 2007 WO
2007114479 Oct 2007 WO
2007125332 Nov 2007 WO
2007130054 Nov 2007 WO
2007130055 Nov 2007 WO
2007141295 Dec 2007 WO
2007142745 Dec 2007 WO
2008036562 Mar 2008 WO
2008036563 Mar 2008 WO
2008106319 Sep 2008 WO
2008157043 Dec 2008 WO
2008157044 Dec 2008 WO
2008157045 Dec 2008 WO
2008157046 Dec 2008 WO
2008157047 Dec 2008 WO
Related Publications (1)
Number Date Country
20080269534 A1 Oct 2008 US
Provisional Applications (1)
Number Date Country
60487364 Jul 2003 US
Continuations (1)
Number Date Country
Parent 10893418 Jul 2004 US
Child 12217311 US